{"title":"肛周克罗恩病的手术治疗","authors":"A. de Buck van Overstraeten","doi":"10.58931/cibdt.2023.1211","DOIUrl":null,"url":null,"abstract":"Virtually one-third of patients with Crohn’s disease (CD) develop anal symptoms. In addition to the typical skin tags and chronic fissures, 50% of these patients develop perianal abscesses and fistulas, which are among the most challenging CD phenotypes to treat. They can significantly affect patients’ quality of life (QOL) and result in a significant amount of lost days at school or work, as they often occur in a young, active population.","PeriodicalId":104720,"journal":{"name":"Canadian IBD Today","volume":"11 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Surgical approaches to perianal Crohn's disease\",\"authors\":\"A. de Buck van Overstraeten\",\"doi\":\"10.58931/cibdt.2023.1211\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Virtually one-third of patients with Crohn’s disease (CD) develop anal symptoms. In addition to the typical skin tags and chronic fissures, 50% of these patients develop perianal abscesses and fistulas, which are among the most challenging CD phenotypes to treat. They can significantly affect patients’ quality of life (QOL) and result in a significant amount of lost days at school or work, as they often occur in a young, active population.\",\"PeriodicalId\":104720,\"journal\":{\"name\":\"Canadian IBD Today\",\"volume\":\"11 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian IBD Today\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.58931/cibdt.2023.1211\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian IBD Today","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.58931/cibdt.2023.1211","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Virtually one-third of patients with Crohn’s disease (CD) develop anal symptoms. In addition to the typical skin tags and chronic fissures, 50% of these patients develop perianal abscesses and fistulas, which are among the most challenging CD phenotypes to treat. They can significantly affect patients’ quality of life (QOL) and result in a significant amount of lost days at school or work, as they often occur in a young, active population.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
